(Q42706490)

5 November 2017

title

Inflammatory myopathy associated with statins: report of three cases (English)

1 reference

5 November 2017

main subject

inflammatory myopathy

1 reference

Michal Tomcik

5

0 references

Herman Mann

object named as

Herman Mann

4

0 references

Jiří Vencovský

object named as

Jiri Vencovsky

3

0 references

author name string

Klara Kuncova

1

1 reference

5 November 2017

Marie Sedlackova

2

1 reference

5 November 2017

Laszlo Wenchich

6

1 reference

5 November 2017

Josef Zamecnik

7

1 reference

5 November 2017

publication date

1 March 2014

1 reference

5 November 2017

1 reference

5 November 2017

volume

24

1 reference

5 November 2017

issue

2

1 reference

5 November 2017

page(s)

366-371

1 reference

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Clinical characterization and molecular mechanisms of statin myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Polymyositis associated with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Atorvastatin-induced dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Polymyositis induced or associated with lipid-lowering drugs: five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Pravastatin-induced dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Lovastatin-associated dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Fluvastatin-induced dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Simvastatin-associated dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Clinical implications of autoantibody screening in patients with autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Diagnostic immunohistology of muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Polymyositis and dermatomyositis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Toxic and drug-induced myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Iatrogenic and toxic myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Statins as immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Effect of coenzyme q10 on myopathic symptoms in patients treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Statin-associated myopathy with normal creatine kinase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

Muscle coenzyme Q10 level in statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.852848

10.3109/14397595.2013.852848

21 January 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference